Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Compare daily and long-term volatility across major coins to inform allocation and risk controls in your portfolio.
20,930 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
CoreWeave’s latest trading session highlighted the tension between high-growth AI clouds and the realities of funding...
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
When a major tariff ruling shifts import costs, retail stocks can respond quickly. This article breaks down why these...
A broad market rally lifted major indexes on Feb. 24 as traders anticipated Nvidia’s earnings and awaited remarks fro...
WTRG just released its quarterly earnings, and the market is parsing revenue growth, margins, and forward guidance. T...
Fame can boost earnings and complicate finances in equal measure. This article uses the idea that dennis quaid once p...
D-Wave Quantum stock gained momentum this week as investors weighed upcoming results and potential partnerships. This...
U.S. stocks open on the back foot as Iran-related tensions flare, pushing futures lower and oil higher. Traders brace...
Goldman Sachs flags four tech, media, and telecom bets on its Conviction List, each carrying 40% to 100% upside to ta...
As the S&P 500 faltered in early 2026, the Simplify Managed Futures Strategy ETF (CTA) posted gains, highlighting a h...